ArticleScientific reports2025
Association between aortic valve calcification and cardiovascular events in patients with chronic kidney disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Valve Disease to Valve Replacement: Lipoprotein(a) Is Associated with Aortic Stenosis Severity but Not Prognosis After TAVI.Medical sciences (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between aortic valve calcification (AVC) and cardiovascular (CV) events across diverse populations including patients with chronic kidney disease (CKD) remains controversial. This study aimed to determine whether AVC is associated with CV events in patients with CKD. In this prospective study, 1,279 participants with CKD were enrolled. A Cox proportional hazard model was applied to determine the association between AVC and CV events. The participants were divided into the following groups according to the number of calcified aortic cusps (CACs): no CACs (n = 922), one CAC (n = 209), and two to three CACs (n = 148). During a median follow-up of 2.9 years, CV events occurred in 185 participants. In multivariable Cox analyses, the hazard ratios (95% confidence intervals) of one CAC and two to three CACs for CV events compared with no CACs were 1.94 (1.32, 2.83) and 2.21 (1.46, 3.33), respectively. In a propensity score-matched cohort, participants with AVC (n = 284) had a significantly higher risk of CV events than those without AVC (n = 284). In CKD, the presence of AVC appears to be an independent risk factor for CV events, and the assessment of AVC is useful in predicting the prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.